Treatment of dissecting aneurysms of the aorta: current status.
D001014:Aortic Aneurysm / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D001027:Aortography; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006406:Hematoma / Q000150:complications; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications; D007629:Kentucky; D008482:Mediastinum; D010996:Pleural Effusion / Q000150:complications; D011433:Propranolol / Q000627:therapeutic use; D011446:Prospective Studies; D012110:Reserpine / Q000627:therapeutic use; D014294:Trimethaphan / Q000627:therapeutic use
D006852:Hydrochlorothiazide; D004295:Dihydroxyphenylalanine; D014294:Trimethaphan; D012110:Reserpine; D011433:Propranolol; D006145:Guanethidine